Genmab — September 2020

[JørgenVarnæs]

Vi fik vist reddet lidt af æren i dag på en uge, der ændrede noget af grundforståelsen af GEN/JJ forholdet. Pensionisten ramte den vist lige bagi med hvad der må være kandidaten til årets citat: “ Katastrofen blev vendt til en møgdag ;-)”

[gentogen]

Det er givetvis rigtigt Helge, men når man bruger dit tidligere link, så fremstår lille uddrag af Sydbanks analyse meget mere negativ end hvis man rent faktsik læser den i sin helhed.Det var bare den lille pointe

[Helge_LarsenPI-redaktør]

Det har du faktisk ret i. Tror dog ikke det er en bevidst handling.

[Helge_LarsenPI-redaktør]

NBI +2,18%

[GeorgeBest]

Efficacy of daratumumab in the treatment of multiple myeloma with high-risk cytogenetics: Meta-analysis of randomized phase III trials https://twitter.com/mtmdphd/status/1309129398990385153?s=21

[Helge_LarsenPI-redaktør]

God morgen.

[E_L]

Daratumumab (anti-CD38) for treatment of disseminated nontuberculous mycobacteria in a patient with anti-IFN-γ autoantibodies https://academic.oup.com/cid/advance-article/doi/10.1093/cid/ciaa1086/5880009

[E_L]

now, i read about Covid-19 and anti-IFN-γ autoantibodies, but it is probably a bit farfetched to make a Dara - Covid link

[transalp]

Go morgen..

[bibob]

God morgen.

[E_L]

I noted Genmab is looking for an Infectious Diseases Scientist and that there is something called "Genmab Infectious Disease initiative" https://genmab.wd3.myworkdayjobs.com/en-US/Genmab_Careers_Site/job/Utrecht/Scientist--Infectious-Diseases_R414

[bibob]

Nice E L. New field for Genmab isn't it. ??

[E_L]

they had a partnership with a small Danish company looooong time ago in infectious diseases, not even sure if that company still exists lol

[peter12]

ACE Biosciences acc to google. Genmab mention infectious disease when describing Duobody platform. Did they cooperate with Amgen about something similar ?

[gentogen]

Faldt lidt tilfældigt over denne gamle nyhed, som jeg ikke havde hørt om før: Tavotek Biotherapeutics Announces a Research Agreement with Genmab for the Development of Bispecific Antibodies using Genmab’s Proprietary DuoBody Technology Platform against a Pair of Disease Relevant Targets

[gentogen]

Tavotek Announces a Research Agreement with Genmab for the Development of Bispecific Antibodies using Genmab's DuoBody® Platform against a Pair of Disease Relevant Targets

/PRNewswire/ -- Tavotek Biotherapeutics, a biotech company which develops novel biologics for autoimmune diseases and oncology, announced that it has entered...

(www.prnewswire.com)

[peter12]

Den har været nævnt her før men lyder spændende

[Plimsoller]

God morgen

[Helge_LarsenPI-redaktør]

God morgen.

[Mogan]

God morgen